Company Daciapharm Srl with Fiscal Code 7041423
recorded a turnover of 2024 of
67.397,
with a net profit of
9.658
and having an average number of employees of
- .
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Daciapharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
659.130
328.030
95.202
68.463
46.880
50.048
56.816
73.356
82.669
67.397
Total Income - EUR
662.500
333.942
151.701
76.357
47.509
51.051
142.280
74.368
84.323
88.481
Total Expenses - EUR
662.010
293.003
137.336
75.391
47.113
50.850
103.649
81.280
92.363
77.712
Gross Profit/Loss - EUR
490
40.940
14.365
966
396
201
38.631
-6.912
-8.040
10.770
Net Profit/Loss - EUR
367
35.460
4.610
13
310
24
32.377
-6.912
-8.040
9.658
Employees
8
0
6
3
4
3
3
2
3
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -18.0%, from 82.669 euro in the year 2023, to 67.397 euro in 2024.
The Net Profit increased by 9.658 euro, from 0 euro in 2023, to 9.658 in the last year.
Check the financial reports for the company - Daciapharm Srl
Financial Rating - DACIAPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Daciapharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Daciapharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Daciapharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
2.607 euro in 2024 which includes Inventories of
0 euro, Receivables of
22 euro and cash availability of
2.585 euro.
The company's Equity was valued at
22.597 euro, while total Liabilities amounted to
10.751 euro.
Equity increased by 9.658 euro, from 13.011 euro in 2023, to 22.597 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Daciapharm Srl